Widely used:Recently Viewed
Clear All$11.87
$1.03
(9.50%)
As on 29-Apr-2025 16:00EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$244 Mln
P/E Ratio
10.31
P/B Ratio
7.81
Industry P/E
--
Debt to Equity
2
ROE
0.62 %
ROCE
27.25 %
Div. Yield
4.48 %
Book Value
1.3
EPS
1.03
CFO
$345.14 Mln
EBITDA
$433.22 Mln
Net Profit
$279.18 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
National Research Corporation (Delaware) (NRC)
| -32.71 | -8.06 | -28.10 | -64.89 | -30.48 | -25.94 | -2.20 |
|
BSE Sensex*
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
National Research Corporation (Delaware) (NRC)
| -55.11 | 6.06 | -10.16 | -1.83 | -34.84 | 75.47 | 5.36 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 44.98 | 7,279.39 | 36.74 | 21.8 | |
| 164.32 | 5,569.58 | 22.19 | 11.9 | |
| 154.26 | 5,991.17 | 21.17 | 27.01 | |
| 89.86 | 7,128.49 | 26.29 | 31.45 |
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare... organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. Address: 1245 Q Street, Lincoln, NE, United States, 68508 Read more
Founder, CEO, President & Director
Mr. Michael D. Hays
Founder, CEO, President & Director
Mr. Michael D. Hays
Headquarters
Lincoln, NE
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of National Research Corporation (Delaware) (NRC) stood at $ 133 Mln as on 31-Dec-24
The share price of National Research Corporation (Delaware) (NRC) is $11.87 (NASDAQ) as of 29-Apr-2025 16:00 EDT. National Research Corporation (Delaware) (NRC) has given a return of -30.48% in the last 3 years.
National Research Corporation (Delaware) (NRC) has a market capitalisation of $ 244 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of National Research Corporation (Delaware) (NRC) is 10.31 times as on 28-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the National Research Corporation (Delaware) (NRC) and enter the required number of quantities and click on buy to purchase the shares of National Research Corporation (Delaware) (NRC).
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. Address: 1245 Q Street, Lincoln, NE, United States, 68508
The CEO & director of Mr. Michael D. Hays. is National Research Corporation (Delaware) (NRC), and CFO & Sr. VP is Mr. Michael D. Hays.
There is no promoter pledging in National Research Corporation (Delaware) (NRC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
715
|
|
|
686
|
|
|
596
|
|
|
586
|
| National Research Corporation (Delaware) (NRC) | Ratios |
|---|---|
|
Return on equity(%)
|
61.77
|
|
Operating margin(%)
|
24.66
|
|
Net Margin(%)
|
17.32
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of National Research Corporation (Delaware) (NRC) was $0 Mln.
